Douglas Lane & Associates’s Versigent PLC VGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.96M Sell
199,399
-62,515
-24% -$2.79M 0.12% 124
2026
Q2
$11M Buy
+261,914
New +$10.4M 0.15% 119

Other funds holding VGNT

Douglas Lane & Associates's VGNT Position: Q3 2026 in Review

Douglas Lane & Associates reduced its Versigent PLC (VGNT) stake by 24% in Q3 2026, selling an estimated $2.79M and leaving 199,399 shares worth $8.96M. The position accounts for 0.12% of the portfolio, ranked #124.

Douglas Lane & Associates first reported a position in VGNT in Q2 2026 and has held it in 2 quarters since. The position peaked at $11M in Q2 2026. 31 funds tracked by Wall St. Rank hold VGNT as of Q3 2026.

  • Douglas Lane & Associates held 199,399 shares of Versigent PLC worth $8.96M as of Q3 2026.
  • Douglas Lane & Associates sold 62,515 Versigent PLC shares in Q3 2026, an estimated $2.79M.
  • Versigent PLC made up 0.12% of Douglas Lane & Associates's portfolio in Q3 2026, its #124 holding.
  • Douglas Lane & Associates first reported a position in Versigent PLC in Q2 2026 and has held it in 2 quarters since.
  • Douglas Lane & Associates's Versigent PLC position peaked at $11M in Q2 2026.
  • 31 funds tracked by Wall St. Rank held Versigent PLC as of Q3 2026.

Based on Douglas Lane & Associates's 13F filing for Q3 2026, filed 9 Oct 2026.